Int. J. Mol. Sci. 2014, 15(5), 8335-8351; doi:10.3390/ijms15058335
Review

Apoptotic Death of Cancer Stem Cells for Cancer Therapy

Received: 24 February 2014; in revised form: 18 April 2014 / Accepted: 18 April 2014 / Published: 12 May 2014
(This article belongs to the Special Issue Programmed Cell Death and Apoptosis 2013)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Cancer stem cells (CSCs) play crucial roles in tumor progression, chemo- and radiotherapy resistance, and recurrence. Recent studies on CSCs have advanced understanding of molecular oncology and development of novel therapeutic strategies. This review article updates the hypothesis and paradigm of CSCs with a focus on major signaling pathways and effectors that regulate CSC apoptosis. Selective CSC apoptotic inducers are introduced and their therapeutic potentials are discussed. These include synthetic and natural compounds, antibodies and recombinant proteins, and oligonucleotides.
Keywords: cancer stem cells; side population; apoptosis; apoptotic inducers; apoptotic death pathways; and cancer therapy
PDF Full-text Download PDF Full-Text [352 KB, uploaded 19 June 2014 05:42 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

He, Y.-C.; Zhou, F.-L.; Shen, Y.; Liao, D.-F.; Cao, D. Apoptotic Death of Cancer Stem Cells for Cancer Therapy. Int. J. Mol. Sci. 2014, 15, 8335-8351.

AMA Style

He Y-C, Zhou F-L, Shen Y, Liao D-F, Cao D. Apoptotic Death of Cancer Stem Cells for Cancer Therapy. International Journal of Molecular Sciences. 2014; 15(5):8335-8351.

Chicago/Turabian Style

He, Ying-Chun; Zhou, Fang-Liang; Shen, Yi; Liao, Duan-Fang; Cao, Deliang. 2014. "Apoptotic Death of Cancer Stem Cells for Cancer Therapy." Int. J. Mol. Sci. 15, no. 5: 8335-8351.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert